Quintana, RosanaPons-Estel, GuillermoRoberts, KarenPalacios Santillán, ErikaRúa-Figueroa, IñigoPego-Reigosa, José M.Ibañez, PabloBerbotto, Leonel ArielBertolaccini, Maria ConstanzaMicelli, Marina LauraPisoni, Ceciliade Souza Barbosa, Vitalinade Ataíde Mariz, HenriqueMachado Ribeiro, FrancinneP.C. Seguro, LucianaInoue Sato, EmiliaMimica Davet, MilenaAroca-Martinez, GustavoBonilla-Abadía, FabioQuintana-López, GerardoSánchez Briones, Reyna ElizabethPérez Cristóbal, MarioSilveira, Luis H.García-De la Torre, IgnacioMorales Avendaño, IvanGámez Siller, PabloPaats Nicora, AstridCieza Calderón, JorgeMendoza Maldonado, Andy ArmandoRebella, MartinSilveira, GonzaloJaramillo, John FredySánchez, MónicaSbarigia, UrbanoOrillion, AshleyZazzetti, FedericoAlarcón, Graciela S.Pons-Estel, Bernardo2025-06-042025-06-042025https://hdl.handle.net/20.500.12442/16645Patients with systemic lupus erythematosus (SLE) are at increased risk of serious infections, which in turn, are associated with morbidity and mortality. The Systemic Lupus Erythematosus Registry of the Spanish Society of Rheumatology (RELESSER) group has developed and internally validated a tool for prediction of serious infections in SLE, with a recently improved version (SLE SI Score Revised or SLESIS-R), being an accurate and reliable instrument. SLESIS-R includes age, previous SLE-related hospitalization, previous serious infection, and glucocorticoid dose. This study aimed to validate SLESIS-R in a multi-ethnic, multi-national Latin-American (LA) SLE cohort.pdfengAttribution-NonCommercial-NoDerivatives 4.0 Internationalinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://www.gladel.org/resources/original/archivos/posters/LUPUS2025/VALIDATION%20OF%20A%20SCORE%20-%20eposter.pdf